Identifying the role of host genetics in influenza susceptibility is paramount for designing effective methods for preventing and treating severe influenza virus infection. Members of the interferon-induced transmembrane (IFITM) protein family prevent influenza and other viruses such as dengue, Ebola, and West Nile from traversing the cell membrane [1] . Animal and in vitro data have confirmed that IFITM protein 3 (IFITM3) restricts influenza virus replication by preventing it from accessing the cytosol [2] [3] [4] . Despite growing data from animal models confirming the important role of IFITM3 in suppressing influenza infection [5, 6] , confirmatory human data that IFITM3 variants influence influenza susceptibility or severity are contradictory.
IFITM3 rs12252_C was first identified as a risk allele for influenza disease severity by Everitt and colleagues. They reported that 3 of 53 white patients in the United Kingdom hospitalized with 2009H1N1 influenza during the pandemic were homozygous for the rs12252_C variant, a frequency that was higher than expected when compared with multiple control groups [4] . A large population dataset [7] reports that the rs12252_C allele is carried by only 8% (41/499) of Europeans. In contrast, carriage of the C allele in individuals with Hispanic, African, and East Asian ancestry is common with 3%, 7%, and 30% of individuals, respectively, predicted to be homozygous, potentially conferring high population-attributable risk. Three studies have identified an association between rs12252_CC homozygotes and influenza infection in adult cohorts. Zhang et al reported that rs12252_CC genotype was associated with influenza severity in Han Chinese [8] . Wang et al reported an increase in viral titers, inflammatory cytokines, and mortality in CC homozygotes in 16 Han Chinese patients infected with H7N9 influenza, a strain that has resulted in increased pathogenicity compared with seasonal influenza [9] . In contrast, Mills and colleagues were unable to replicate an association with rs12252_CC and severe influenza in a large mostly white multicenter cohort, although 2 of 232 patients with mild influenza were homozygous [10] .
A mechanistic connection between IFITM3 rs12252_C and influenza disease has not been fully elucidated. Although it is a putative splice-site altering polymorphism proposed to encode an IFITM3 isoform (Δ21 IFITM3) lacking 21 amino acids at the amino terminus [4] , the splice variant (ENST00000526811) was not detected in the HapMap lymphoblastoid cell lines with CC genotype [4] . Overexpression of full-length IFITM3 and Δ21 IFITM3 did show a difference in restriction of viral replication in A549 cells, however Williams and colleagues found that the Δ21 IFITM3 isoform effectively restricted entry of influenza H1, H3, H5, and H7 viruses and efficiently suppressed replication of H1N1 with an attenuated effect on H3N2 [11] . Additionally, the transcript support level in Ensembl (accessed 2 February 2017) [12] states that the alternate transcript is not currently supported by either messenger RNA or an expressed sequence tag (EST).
The aim of this study was to determine if the IFITM3 rs12252 variant was associated with influenza infection in a multicenter cohort of children admitted to the pediatric intensive care unit (PICU) with confirmed influenza-related critical illness. We also sought to identify additional relevant mutations, so we sequenced IFITM3 and evaluated linkage disequilibrium across identified variants. We evaluated rs12252 for association with influenza infection susceptibility and severity using family-based (parent-to-child transmission) and population-based approaches. We also assessed the genotype distribution of rs12252 in a second population of African American children with outpatient influenza infection. In addition, we used patient RNA to determine if rs12252 was a splice site in our populations.
METHODS
We prospectively enrolled children (age <21 years) across 38 Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network PICUs that voluntarily participated in the Pediatric Influenza (PICFLU) Genetic Susceptibility Study from November 2008 to April 2016. Patients presenting to the PICU with critical illness (acute respiratory failure and/or vasopressors) suspected of having an influenza infection (tested and/ or influenza antivirals ordered) were eligible. We excluded those with immunosuppressive or severe underlying respiratory, metabolic cardiac, neurologic, or other condition(s) predisposing them to more severe illness. Detailed inclusion/ exclusion criteria are provided in the Supplementary Data. We collected patient demographic and clinical data, flocked nasopharyngeal swabs, and endotracheal aspirates for additional viral testing, and samples from children (blood) and parents (saliva) for DNA extraction. The institutional review boards at each site approved the study and at least 1 parent gave informed consent. Parental genotypes were used as a family-based control group. Influenza infection was confirmed by a positive viral test. Bacterial respiratory coinfection was defined as a clinical report of culture of an organism from the endotracheal, blood and/ or pleural fluid within 72 hours of PICU admission with concomitant diagnosis by treating physicians. Severity of illness was assessed by Pediatric Risk of Mortality (PRISM) III score. Additional definitions are in the Supplementary Data.
African American children from the FLU09 cohort (outpatients with polymerase chain reaction [PCR]-confirmed influenza infection) were included to enrich the number of subjects in this ethnic group and to control for influenza illness severity [13] . The 1000 Genomes Project database (http://www.1000ge-nomes.org/) served as the population-based control group [7] .
Genotyping and Gene Expression
Human IFITM3 sequences were amplified for probands using nested PCR. Analysis was performed using SeqScape version 2.5 analysis software (Applied Biosystems). We genotyped DNA from parents (rs12252, and variants rs1136853 and rs34481144 to create haplotypes) and PICU controls (rs12252) using TaqMan assays at a core facility. The Supplementary Data include additional details of sequencing and PICFLU and FLU09 genotyping methods. Total RNA was extracted from peripheral blood mononuclear cells (PBMCs) from 45 FLU09 influenza-infected patients who had mild to severe clinical outcomes. Quality and quantity of RNA samples were determined prior to their processing by RNA-seq. The concentration of RNA samples was determined using NanoDrop 8000 (Thermo Scientific) and the integrity of RNA was determined by Fragment Analyzer (Advanced Analytical Technologies). One microgram of total RNA was used as an input material for library preparation using TruSeq RNA Sample Preparation Kit version 2 (Illumina). Size of the libraries was confirmed using Fragment Analyzer (Advanced Analytical Technologies) and their concentration was determined by quantitative PCR-based method using Library quantification kit (KAPA). The libraries were multiplexed and then sequenced on Illumina HiSeq2500 (Illumina) to generate 30M of single-end 50 base pair reads. FASTQ sequences were mapped to the human hg19 genome by a pipeline that employs STAR [14] and BWA [15] . Mapped reads were counted with HTSEQ [16] and gene-level fragments per kilobase million (FPKM) values were computed, and the data were log 2 transformed. Exon junctions were extracted by mapping them to a combined database of known and potential exon junctions derived from Refseq, Aceview, and Ensembl annotations using an in-house pipeline. Quality control, statistical analyses, and visualizations were performed using Partek Genomics Suite 6.6 (St Louis, Missouri) and Stata MP/14.1 (College Station, Texas). From these samples, 44 were successfully genotyped for rs12252 and used for eQTL analysis. eQTL analysis for FLU09 RNAseq data was performed using the analysis of variance (ANOVA) test in RStudio. Power was calculated using G*Power Version 3.1.9.2 [17] using α = .05 and effect size from the published GTEX rs12252 eQTL for IFITM3 in whole blood (www.gtexportal.org/home/; accessed 30 March 2017). For our sample size at the published effect size, we had 91% power to detect an association. Power remained >80% for our analysis even if the effect size was reduced to <0.5. RNA samples from PICFLU were assayed using the HuGene-1 st v1 array (Affymetrix, Mountain View, California). The CEL files were processed and splicing was analyzed using the ANOVA model in Partek Genomics Suite 6.6.
Statistical Analyses
Categorical variables were compared using χ 2 test or Fisher exact tests and continuous variables with the Wilcoxon-Mann-Whitney test. Linkage disequilibrium among the IFITM3 single-nucleotide polymorphisms (SNPs) was evaluated with Haploview (www. broadinstitute.org) [18] . Allele frequencies of rs12252 varied by ethnic group in 1000 Genomes [7] (Supplementary Table 3 ). To minimize confounding by population substructure, we used a family-based analysis with transmission disequilibrium testing for the 3 principal SNPs using all subjects and white subjects. The software FBAT/PBAT [19, 20] (www.hsph.harvard.edu/fbat) was used to analyze the pedigrees using first the basic FBAT test and then HBAT to explore haplotype transmission (minimum informative families = 10) testing additive, dominant, and recessive models and PBAT to calculate the final transmission disequilibrium test (TDT) results and statistical power.
We used PLINK [21] (available at http://pngu.mgh.harvard. edu/~purcell/plink/) to explore the associations in PICFLU whites of the rs12252 IFITM3 SNP with the continuous phenotype of PRISM-III severity of illness score (untransformed and log-transformed) and with the dichotomous outcomes of mechanical ventilation, receipt of extracorporeal membrane oxygenation (ECMO), mortality, and acute lung injury. We also assessed whether rs12252 was associated with a clinical diagnosis of bacterial coinfection or type of influenza (A or B). Association was tested using the allele test.
RESULTS
We enrolled 393 children and included 358 (259 white) with a positive test for influenza virus from their respiratory tract in the PICFLU study. Table 1 shows the characteristics of the patients and the types of viral and bacterial infections identified. Severity of illness was high; 85% of children received some form of mechanical ventilator support for acute respiratory failure, 41% received vasoactive agents for cardiovascular support, and 6% of patients died.
IFITM3 rs1136853 and rs12252 were significantly out of Hardy Weinberg equilibrium (HWE) in the influenza-positive patients overall and in non-Hispanic whites (Table 2) , with higher than expected rare homozygotes. However, comparisons of the distribution of PICFLU genotypes in the cases vs the 1000 Genomes European and control group did not reach significance. Carriage of the C allele is higher in African cohorts compared with whites in 1000 Genomes. As shown in Table 2 , there was also no evidence of higher than expected rs12252_CC homozygotes in 56 African American children in PICFLU or in 54 African American children from the FLU09 study [13] . There was an increase in carriage of Table 4 ).
To identify rare variants with pathogenic potential, we sequenced IFITM3 in PICFLU patients. All variants identified are shown in Supplementary Table 2. There were no novel rare variants with pathogenic potential detected, nor were there any patients with rare homozygous or compound heterozygous mutations in the exons of IFITM3.
Using family-based analyses to control for potential confounding by racial stratification, we did not identify significant a Families with at least 1 heterozygous parent are included.
b The probability that under binary outcome and modeling assumptions, the transmission disequilibrium test with this number of families would have detected a difference of α < .05, 2-sided.
c PICFLU cohort restricted to families self-identifying as white. overtransmission of alleles from heterozygous parents for the 3 SNPs tested including rs12252_C (Table 3) . Although there was a trend (P = .11 for rs12252, the trend was for increased transmission of the T allele. Power to detect an association at P < .05 was 100% for all models. Figure 1 shows the linkage disequilibrium among the SNPs identified in IFITM3. The 3 SNPs we evaluated were had high D' but low r 2 showing that some haplotypes were missing and consistent with the haplotypes identified using HBAT (distribution shown in Supplementary Figure 1) . Interestingly, the rs12252_C allele was never carried with the rs34481144_A allele in parents or children in the PICFLU cohort. In addition, the 2 non-Hispanic individuals homozygous for the rare variant missense variant rs1136853_A were also homozygous for rs12252_C. With only 4 informative families, we lacked statistical power to test transmission of rs1136853AA in the recessive model (Table 3 ). Of note, the 2 haplotypes that include the rs12252_C allele were also not associated using HBAT analysis in the additive model (Supplementary Table 4 ). We were interested to examine whether the published association of rs12252_C carriage with increased disease severity in hospitalized Chinese populations extends to our predominantly white pediatric cohort. The phenotype analysis by allele for the rs12252 SNP in 259 white children did not reveal associations for higher carriage of the rs12252_C allele with PRISM severity of illness scores (untransformed P = .87; log-transformed P = .74). rs12252_C carriage was also not higher in the 73% of children who received mechanical ventilation (n = 188; odds ratio [OR], 1.1; P = .80), in the 13% who received ECMO support (n = 33; OR, 1.87; P = .13), or in the 16 children who died (OR, 0.38; P = .33). Diagnosis of acute lung injury (n = 110 [42.5%]; OR, 0.58; P = .12) or bacterial coinfection (n = 82 [32%]; OR, 0.84; P = .63) were not associated. There was no difference in allele distribution between 207 children (80%) with influenza A vs 52 (20%) with influenza B (OR, 1.03; P = .94).
The lack of observed association of rs12252 in our critically ill predominantly white influenza cohort prompted us to examine whether a truncated RNA encoding the Δ21 IFITM3 isoform predicted by the rs12252 splice site variant could be detected in rs12252_CC carriers. We investigated RNAseq data from 44 influenza-infected patients from the FLU09 study for any evidence of the splice isoform. From this dataset, 3 individuals were homozygous for the C allele of rs12252. Despite having 3 homozygous individuals, the putative rs12252 splice isoform ENST00000526811 [4] was not observed (Figure 2) . We did find a very small frequency of other isoforms represented in Figure  2 , none of which were the Δ21 IFITM3 isoform (Figure 2 ). We also found no evidence of the Δ21 IFITM3 isoform in expression data from a subset of PICFLU patients (Supplementary Figure 2) . These data show that in our cohorts we found no evidence for a functional consequence of rs12252 genotype on IFITM3 splicing, with the Δ21 IFITM3 isoform not detected and no eQTL association found (P = .25; Figure 2 ). Figure 1 . Linkage disequilibrium (r 2 ) in the white and influenza-positive subjects (n = 259) using a minor allele frequency of 0.01 as calculated by Haploview (www.broadinstitute.org) [18] . The following color scheme applies: white: r 2 = 0; shades of gray: r 2 = 0 to <1; black: r 2 = 1. The r 2 values are listed within each cell.
DISCUSSION
Publications of genetic associations in existing cohorts of otherwise healthy, severely ill humans with influenza infection have been relatively small and results are inconsistent across cohorts, thus limiting conclusions about the role of host genetics [22] . Children have been particularly understudied, despite being an at-risk population. We sought to address this by developing the PICFLU cohort, a large representative group of US children with influenza-related critical illness without underlying conditions predisposing them to such severe infection. Collection of parental DNA allowed us to use both family-and population-based methods to evaluate potential gene-disease associations. The IFITM3 rs12252_C allele, previously reported as strongly associated with influenza susceptibility and/or severity in adults, was not associated with susceptibility for influenza critical illness in these children using a family-based analysis or with severity of illness within the cohort. This was also true for African American children, where carriage of the C allele is more common than in whites. In addition, we did not find evidence of the truncated RNA encoding the Δ21 IFITM3 isoform to support rs12252 as a splice site, suggesting that prior observed associations between rs12252 and influenza disease severity in adult populations may result from a yet undescribed mechanism.
Despite enrolling across a representative sample of US PICUs since 2008 and during the 2009 pandemic, our cohort of 358 children was mainly comprised of whites and has limited power to assess IFITM3 in multiple ethnic subgroups. Although our results were confirmed in a second pediatric African American outpatient population, we did not have sufficient numbers of Hispanic or East Asian patients to evaluate rs12252 where C is the major allele and homozygosity is common. In addition, the PICFLU cohort included only severe cases of influenza infection; we were not able to evaluate associations with milder cases. We report important linkage disequilibrium between rs12252 and rs34481144 in the IFITM3 gene; the C allele of the first SNP is not carried with the A allele of the second, indicating 2 possible risk haplotypes. In the 1000 Genomes Project database [7] , the rs34481144_A allele is carried by 46.2% of Europeans whereas <1% of East Asians carry it (accessed 27 January 2017, 1000genomes.org).
Because the C allele of rs12252 is rare in individuals of European ancestry, homozygosity is even more infrequent, with none identified in 503 subjects from the 1000 genomes control population [7] . Most reported associations between rs12252 and influenza susceptibility in white cohorts have rested on identification of a small number of CC homozygotes in Europeans with influenza infection compared to few to none in larger population control cohorts. Everitt et al reported homozygosity in 3 of 53 adults hospitalized with 2009H1N1 [4] . In whites, Mills et al identified 2 in 259 with mild influenza vs 4 in 2623 controls [10] . López-Rodríguez et al found 1 in 58 individuals with mild influenza illness but zero in 60 patients with severe influenza infection [23] . We identified 2 rs12252_CC homozygotes in 185 white non-Hispanic children with influenza critical illness. Predicted to be even more uncommon, these 2 individuals were also homozygous for the rare minor allele of the IFITM3 H3Q rs1136853 missense mutation; however, it is predicted to be benign and upon stably induced challenge of influenza virus infected cell lines was indistinguishable from wild type [24] . Given the high level of admixture in the white population in the United States, we believe that use of parental genotype with family-based testing adequately controls for racial stratification. In a cohort with sufficient statistical power, we did not identify overtransmission of the rs12252_C allele from heterozygous parents in additive or recessive models. This evidence does not support rs12252_C homozygosity as a susceptibility genotype for severe influenza in white children, but we lacked sufficient power to test the rs1136853_A/rs12252_C homozygous genotype. The PICFLU cohort is a major strength of this study. Children were enrolled across multiple large PICUs, diagnostic testing was rigorous, and extensive clinical phenotype information was collected. Influenza critical illness is not common in children without known risk factors for severe disease, enriching the cohort for genetic factors. In summary, we failed to confirm an association between the rs12252_C allele of IFITM3 and influenza susceptibility in 2 cohorts of children. Future studies in large clinically characterized cohorts with diverse ethnicities are important to better understand how genetics shapes the susceptibility to and severity of influenza infection.
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